An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.

• Main Authors: Purushothaman Jambulingam (Author), Vijesh Sreedhar Kuttiatt (Author), Kaliannagounder Krishnamoorthy (Author), Swaminathan Subramanian (Author), Adinarayanan Srividya (Author), Hari Kishan K Raju (Author), Manju Rahi (Author), Roopali K Somani (Author), Mallanna K Suryaprakash (Author), Gangeshwar P Dwivedi (Author), Gary J Weil (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) o...